Last Updated: 16/02/2024
Medicines for All Institute: Low Cost Manufacturing for GH drugs
Objectives
To reduce the Active Pharmaceutical Ingredient (API) manufacturing cost for a wide range of global health drugs either in market or in development to improve patient access and enable uptake of critical GH medicines.
External reference
Thematic Categories
Date
Mar 2023 — Apr 2028
Total Project Funding
$21.54M
Funding Details
Gates Foundation (GF), United States
INV-052392
Project Site
Related Resources
